A clinical trial to study the effect of single drug, Tukhme Khurfa in patients with heavy menses

Efficacy of Tukhme Khurfa in Istehaza- An open observational clinical study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012593

Enrollment

Registered

2018-03-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Abnormal Uterine Bleeding patients

Interventions

Intervention1: Tukhme Kurfa: 2gm thrice a day for 10 days starting from 1st day of menses Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Heavy irregular bleeding Vaginal bleeding increased in amount or duration Patient affected from istehaza for 3 months

Exclusion criteria

Exclusion criteria: pregnancy and lactation systemic, metabolic illness and malignancy severe aneamia ( IUCDs recent H/O of chikengunia and dengue

Design outcomes

Primary

Measure	Time frame
Change in PBSC score Menstrual regulationTimepoint: 4months	—

Secondary

Measure	Time frame
Change in SF-12 score Change in HB%Timepoint: 4 months	—

Countries

India

Contacts

Public ContactBenazir Khanam

Rajiv gandhi university of health science

drwajeehanium@gmail.com09972550185

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026